BASF to spend €200m to up ibuprofen capacity in Europe and US

By Gareth Macdonald contact

- Last updated on GMT

iStock/Zerbor
iStock/Zerbor
BASF has said it will build an ibuprofen plant in Ludwigshafen, Germany and increase production capacity for the API at a facility in Bishop, Texas in the US.

The German chemicals firm described the new facility – which is due to be operational in 2021 – as the “first world-scale ibuprofen plant in Europe​.”

BASF said the Texas plant expansion is designed to "fill current supply gaps for ibuprofen in the market​" adding that the "expansion will come onstream in early 2018​."

The company said it will invest approximately €200m ($227m) in both projects.

Ibuprofen is one of only a handful of active pharmaceutical ingredients (APIs) that BASF still makes. 

The firm sold most of its drug ingredient portfolio and several manufacturing facilities to Swiss firm Siegfried Holdings in 2015​. The only APIs that BASF retained, in addition to ibuprofen, were its portfolio of omega-3 based actives. 

BASF declined to disclose its current ibuprofen production capacity when contacted by in-Pharmatechnologist, but did say it "is a market leader for Ibuprofen in regards to sales and total capacity​."

The firm also told us "the investment will create in Ludwigshafen additional jobs that number in the range of the middle double digits​."

API business

BASF's remaining API business had a mixed 2016.

In July​ last year the firm reported that lower demand for drug actives had seen sales volumes dip in its nutrition & health division.

However, in its full year report​ BASF said the division had seen sales volumes increase, explaining that "demand grew, especially in the pharmaceuticals and animal nutrition businesses​."

Related news

Show more

Related product

TCC TB – a new filler for direct compression

TCC TB – a new filler for direct compression

Jungbunzlauer | 09-Oct-2017 | Technical / White Paper

TCC TB is a tricalcium citrate tetrahydrate designed to function as a direct compression excipient. It combines exceptional compression characteristics,...

Related suppliers